Market Momentum: BioAtla Inc (BCAB) Registers a -2.85% Decrease, Closing at $0.82

Kevin Freeman

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

BioAtla Inc (NASDAQ: BCAB) closed the day trading at $0.82 down -2.85% from the previous closing price of $0.85. In other words, the price has decreased by -$2.85 from its previous closing price. On the day, 0.57 million shares were traded. BCAB stock price reached its highest trading level at $0.8834 during the session, while it also had its lowest trading level at $0.812.

Ratios:

For a better understanding of BCAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.54.

On September 15, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.JMP Securities initiated its Mkt Outperform rating on September 15, 2022, with a $17 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 48432924 and an Enterprise Value of 46293924.

Stock Price History:

The Beta on a monthly basis for BCAB is 1.00, which has changed by -0.49135804 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, BCAB has reached a high of $1.72, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 4.87%, while the 200-Day Moving Average is calculated to be 62.64%.

Shares Statistics:

Over the past 3-months, BCAB traded about 1.48M shares per day on average, while over the past 10 days, BCAB traded about 1702670 shares per day. A total of 58.79M shares are outstanding, with a floating share count of 45.62M. Insiders hold about 22.39% of the company’s shares, while institutions hold 15.75% stake in the company. Shares short for BCAB as of 1763078400 were 4783598 with a Short Ratio of 3.24, compared to 1760486400 on 3000731. Therefore, it implies a Short% of Shares Outstanding of 4783598 and a Short% of Float of 9.120000000000001.

Earnings Estimates

Current recommendations for the stock of the company come from 1.0 analysts.

Analysts are recommending an EPS of between -$1.08 and -$1.08 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.92, with 1.0 analysts recommending between -$0.92 and -$0.92.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.